Researchers found that deguelin could inhibit the proliferation, invasion, metastasis, and autophagy of tumor cells by regulating many signal pathways (e.g., EGFR/IGF1R-Akt, MAPK, and mTOR). The gene discussed is EGFR; the disease is neoplasm.